** Shares in Gerresheimer GXIG.DE fall 8% in early Frankfurt trade after the German medical equipment maker cut its full-year outlook
** It now sees its revenues declining organically by between 4% and 2%, compared to its previous expectation for growth of 0-2%; adjusted EBITDA margin is expected to be around 18.5 to 19% versus around 20% seen previously
** "This news, while unwelcome, may not come as a complete surprise for some," Jefferies says, pointing to sellside consensus already falling below the company's medium-term plans
** According to a local trader a key question will be whether investors will step back to purchase the company when shares have fallen below 30 EUR
(Reporting by Simon Ferdinand Eibach)
((Simonferdinand.eibach@thomsonreuters.com))